Insights
56 articles
Pharmacovigilance (PV) has evolved from a primarily operational reporting function into a strategic component of the life sciences ecosystem. As regulatory expectations become increasingly complex and products are…
Expanding a pharmaceutical product into a new country can open significant opportunities for growth, but market entry is not simply a regulatory submission or commercial decision. Once a…
Brazil has established a comprehensive pharmacovigilance framework designed to ensure the continuous monitoring of the safety and benefit–risk profile of medicinal products throughout their lifecycle. The Agência Nacional…
In today’s global pharmaceutical environment, medicinal products are often developed, manufactured, marketed, and distributed across multiple countries and by several organizations. As a result, important safety information may…
In pharmacovigilance, the identification of a potential safety signal is the beginning of a structured scientific and regulatory process—not the conclusion. A safety signal may arise from spontaneous…
Gene and cell therapies are transforming modern medicine by offering treatments that target the underlying causes of disease rather than merely managing symptoms. These advanced therapy medicinal products…
Australia is recognized as one of the world’s most respected and highly regulated pharmaceutical markets. With a strong healthcare system, rigorous regulatory oversight, and internationally recognized quality standards,…
Pharmacovigilance (PV) inspections are no longer viewed as isolated regulatory events—they are an essential mechanism for ensuring that Marketing Authorization Holders (MAHs) maintain effective pharmacovigilance systems that protect…
For pharmaceutical companies operating globally, maintaining consistent and compliant product information is one of the most complex aspects of lifecycle management. The Company Core Data Sheet (CCDS) serves…
As pharmaceutical companies continue expanding into global markets, pharmacovigilance (PV) professionals are increasingly required to navigate multiple regulatory frameworks simultaneously. While the European Union’s Good Pharmacovigilance Practices (EU…
Every medicinal product carry benefits and risks. While many risks can be managed through routine measures such as product labelling and prescribing information, some require additional interventions to…
The post-approval phase of a medicinal product’s lifecycle represents a critical period for continuous safety monitoring. As medicines are exposed to larger and more diverse patient populations, new…
In pharmacovigilance and drug safety systems, data integrity is not just a regulatory expectation it is a fundamental requirement for ensuring patient safety and maintaining trust in medicinal…
The increasing availability of biosimilar medicinal products has transformed healthcare by expanding patient access to life-saving biological therapies while reducing treatment costs. Biosimilars are highly similar to an…
Pharmacovigilance (PV) plays a critical role in ensuring patient safety by monitoring, detecting, assessing, and preventing adverse effects associated with medicinal products. While developed nations have established robust…
Talk to our experts and get tailored solutions to help you stay compliant and move forward with confidence.
Submit RFI/RFP
Request Consultation
Submit RFI/RFP